Search results
If You'd Invested $25,000 in Viatris in 2020, This Is How Much You Would Have Today
Motley Fool· 10 months agoViatris (NASDAQ: VTRS) spun off from Pfizer and merged with Mylan back in 2020. It's a generic...
Is Viatris a Great Dividend Stock or Just a Value Trap?
Motley Fool via Yahoo Finance· 3 months agoViatris (NASDAQ: VTRS) is a large and diverse pharmaceutical business that spun off from Pfizer in...
Better Dividend Stock: AbbVie or Viatris?
Motley Fool· 2 years agoAbbVie (NYSE: ABBV) and Viatris (NASDAQ: VTRS) have a lot more in common than first glances would suggest. The two were both spun off from larger...
Could Viatris Stock Help You Become a Millionaire?
Motley Fool· 9 months agoViatris' broad portfolio gives the business lots of stability and plenty of opportunities -- but is there enough there for the stock to be a great...
Viatris Stock: Bull vs. Bear
Motley Fool· 11 months agoIt sells a wide variety of generic drugs -- such as generic Zyrtec allergy pills -- as well as branded medicines like cholesterol drug Lipitor. The...
Wall Street Thinks Viatris Stock Will Rise 25% -- Could It Grow Even More?
Motley Fool· 12 months agoFor a generic drugmaker like Viatris (NASDAQ: VTRS), big spurts of growth are unlikely. The market...
These 2 Dividend Stocks Yield 5% -- and They Aren't Risky Buys
Motley Fool· 1 year agoViatris (NASDAQ: VTRS) and Enbridge (NYSE: ENB) are two stocks with high yields that look fairly...
These Are 3 of the Nasdaq's Cheapest Dividend Stocks
Motley Fool· 1 year agoThe Nasdaq Composite is often associated with high-powered growth stocks. Three stocks that could potentially give you the best of both worlds are...
3 Healthcare Spinoffs Worth a Look, But 1 Has the Best Long-Term Potential
Motley Fool· 1 year agoHealthcare spinoffs aren't normally seen as companies with strong growth potential. More likely than...
3 Stocks With Dividends of 3% or More to Buy on the Dip
Motley Fool· 2 years agoFresenius Medical Care (NYSE: FMS), Pfizer (NYSE: PFE), and Viatris (NASDAQ: VTRS) have seen their...
